Mutlu, H. Et Al. 2012. Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer. Clinical and Applied Thrombosis/Hemostasis , vol.18, no.5 , 546-548.

Mutlu, H., Berk, V., Karaca, H., Erden, A., Aslan, T., & Akca, Z., (2012). Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer. Clinical and Applied Thrombosis/Hemostasis , vol.18, no.5, 546-548.

Mutlu, Hasan Et Al. "Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer," Clinical and Applied Thrombosis/Hemostasis , vol.18, no.5, 546-548, 2012

Mutlu, Hasan Et Al. "Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer." Clinical and Applied Thrombosis/Hemostasis , vol.18, no.5, pp.546-548, 2012

Mutlu, H. Et Al. (2012) . "Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer." Clinical and Applied Thrombosis/Hemostasis , vol.18, no.5, pp.546-548.

@article{article, author={Hasan Mutlu Et Al. }, title={Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer}, journal={Clinical and Applied Thrombosis/Hemostasis}, year=2012, pages={546-548} }